Afinitor Disperz
Term · Oncology and biomedicine · MLC-T-ONC-000310
A drug that contains the active ingredient everolimus and is used to treat a type of benign brain tumor called subependymal giant cell astrocytoma and certain types of seizures in patients who have tuberous sclerosis. Afinitor Disperz blocks a protein involved in cell division, which may help keep abnormal cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. It may also help prevent or treat seizures in some patients. Afinitor Disperz is a type of kinase inhibitor and a type of angiogenesis inhibitor.
| Identifier | MLC-T-ONC-000310 |
|---|---|
| Field | Oncology and biomedicine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000310",
"term": "Afinitor Disperz",
"field": "Oncology and biomedicine",
"definition": "A drug that contains the active ingredient everolimus and is used to treat a type of benign brain tumor called subependymal giant cell astrocytoma and certain types of seizures in patients who have tuberous sclerosis. Afinitor Disperz blocks a protein involved in cell division, which may help keep abnormal cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. It may also help prevent or treat seizures in some patients. Afinitor Disperz is a type of kinase inhibitor and a type of angiogenesis inhibitor.",
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/afinitor-disperz/"
}
Record 525 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.